The invention provides compounds and pharmaceutical compositions thereof, which are useful for modulating EGFR activity, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated EGFR activity.
本发明提供了可用于调节
表皮生长因子受体活性的化合物及其药物组合物,以及使用此类化合物治疗、改善或预防与
表皮生长因子受体活性异常或失调相关的病症的方法。